Hanninen, M., Venner, P., & North, S. (2013). A rapid PSA half-life following docetaxel chemotherapy is associated with improved survival in hormone refractory prostate cancer. Canadian Urological Association Journal, 3(5), 369–74. https://doi.org/10.5489/cuaj.1145